FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Patricia Blount

Research Profile

Disorders

Physiology

Concepts & Ideas

Procedures

Anatomy

Chemicals & Drugs

Genes & Molecular Sequences

Co-author Network

Publications

TOP 3
Sheetal Hardikar; Robert D Odze; Lynn Onstad; Brian J Reid; Patricia L Blount; Thomas L Vaughan
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
Elizabeth D Kantor; Lynn Onstad; Brian J Reid; Patricia L Blount; Thomas L Vaughan
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
Lauren M F Merlo; Najaf A Shah; Xiaohong Li; Patricia L Blount; Thomas L Vaughan; Brian J Reid; Carlo Maley
A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Patricia Blount (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sheetal Hardikar; Robert D Odze; Lynn Onstad; Brian J Reid; Patricia L Blount; Thomas L Vaughan
The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus.
PloS one 2013;8(1):e52192.
2012: Elizabeth D Kantor; Lynn Onstad; Brian J Reid; Patricia L Blount; Thomas L Vaughan
Use of statin medications and risk of esophageal adenocarcinoma in persons with Barrett's esophagus.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2012;21(3):456-61.
2010: Lauren M F Merlo; Najaf A Shah; Xiaohong Li; Patricia L Blount; Thomas L Vaughan; Brian J Reid; Carlo Maley
A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma.
Cancer prevention research (Philadelphia, Pa.) 2010;3(11):1388-97.
2008: Xiaohong Li; Patricia C Galipeau; Carissa A Sanchez; Patricia L Blount; Carlo Maley; Jessica Arnaudo; Daniel A Peiffer; Dmitry Pokholok; Kevin L Gunderson; Brian J Reid
Single nucleotide polymorphism-based genome-wide chromosome copy change, loss of heterozygosity, and aneuploidy in Barrett's esophagus neoplastic progression.
Cancer prevention research (Philadelphia, Pa.) 2008;1(6):413-23.
2008: Thomas G Paulson; Patricia C Galipeau; Lianjun Xu; Heather D Kissel; Xiaohong Li; Patricia L Blount; Carissa A Sanchez; Robert D Odze; Brian J Reid
p16 mutation spectrum in the premalignant condition Barrett's esophagus.
PloS one 2008;3(11):e3809.
2007: Rosa-Ana Risques; Thomas L Vaughan; Xiaohong Li; Robert D Odze; Patricia L Blount; Kamran Ayub; Jasmine L Gallaher; Brian J Reid; Peter S Rabinovitch
Leukocyte telomere length predicts cancer risk in Barrett's esophagus.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(12):2649-55.
2007: Sid H Siahpush; Thomas L Vaughan; Johanna N Lampe; Robert Freeman; Skay Lewis; Robert D Odze; Patricia L Blount; Kamran Ayub; Peter S Rabinovitch; Brian J Reid; Chu Chen
Longitudinal study of insulin-like growth factor, insulin-like growth factor binding protein-3, and their polymorphisms: risk of neoplastic progression in Barrett's esophagus.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(11):2387-95.
2007: Amitabh Srivastava; Jason L Hornick; Xiaohong Li; Patricia L Blount; Carissa A Sanchez; David S Cowan; Kamran Ayub; Carlo Maley; Brian J Reid; Robert D Odze
Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
The American journal of gastroenterology 2007;102(3):483-93; quiz 694.
2007: Patricia C Galipeau; Xiaohong Li; Patricia L Blount; Carlo Maley; Carissa A Sanchez; Robert D Odze; Kamran Ayub; Peter S Rabinovitch; Thomas L Vaughan; Brian J Reid
NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma.
PLoS medicine 2007;4(2):e67.
2006: Jonathan N Glickman; Patricia L Blount; Carissa A Sanchez; David S Cowan; V Jon Wongsurawat; Brian J Reid; Robert D Odze
Mucin core polypeptide expression in the progression of neoplasia in Barrett's esophagus.
Human pathology 2006;37(10):1304-15.
2006: Jennifer C Finley; Brian J Reid; Robert D Odze; Carissa A Sanchez; Patricia C Galipeau; Xiaohong Li; Steven G Self; Katherine A Gollahon; Patricia L Blount; Peter S Rabinovitch
Chromosomal instability in Barrett's esophagus is related to telomere shortening.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(8):1451-7.
2006: Leslie C Lomo; Patricia L Blount; Carissa A Sanchez; Xiaohong Li; Patricia C Galipeau; David S Cowan; Kamran Ayub; Peter S Rabinovitch; Brian J Reid; Robert D Odze
Crypt dysplasia with surface maturation: a clinical, pathologic, and molecular study of a Barrett's esophagus cohort.
The American journal of surgical pathology 2006;30(4):423-35.
2006: Carlo Maley; Patricia C Galipeau; Jennifer C Finley; V Jon Wongsurawat; Xiaohong Li; Carissa A Sanchez; Thomas G Paulson; Patricia L Blount; Rosa-Ana Risques; Peter S Rabinovitch; Brian J Reid
Genetic clonal diversity predicts progression to esophageal adenocarcinoma.
Nature genetics 2006;38(4):468-73.
2006: Thomas G Paulson; Lianjun Xu; Carissa Sanchez; Patricia L Blount; Kamran Ayub; Robert D Odze; Brian J Reid
Neosquamous epithelium does not typically arise from Barrett's epithelium.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1701-6.
2006: V Jon Wongsurawat; Jennifer C Finley; Patricia C Galipeau; Carissa A Sanchez; Carlo Maley; Xiaohong Li; Patricia L Blount; Robert D Odze; Peter S Rabinovitch; Brian J Reid
Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(3):509-16.
2005: Thomas L Vaughan; Linda M Dong; Patricia L Blount; Kamran Ayub; Robert D Odze; Carissa A Sanchez; Peter S Rabinovitch; Brian J Reid
Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study.
The lancet oncology 2005;6(12):945-52.
2005: Alan R Kristal; Patricia L Blount; Jeannette M Schenk; Carissa A Sanchez; Peter S Rabinovitch; Robert D Odze; Judi Standley; Thomas L Vaughan; Brian J Reid
Low-fat, high fruit and vegetable diets and weight loss do not affect biomarkers of cellular proliferation in Barrett esophagus.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(10):2377-83.
2005: Jason L Hornick; Patricia L Blount; Carissa A Sanchez; David S Cowan; Kamran Ayub; Carlo Maley; Brian J Reid; Robert D Odze
Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's esophagus.
The American journal of surgical pathology 2005;29(3):372-80.
2004: Carlo Maley; Patricia C Galipeau; Xiaohong Li; Carissa A Sanchez; Thomas G Paulson; Patricia L Blount; Brian J Reid
The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.
Cancer research 2004;64(20):7629-33.
2003: Rebecca E Rudolph; Thomas L Vaughan; Alan R Kristal; Patricia L Blount; Douglas S Levine; Patricia C Galipeau; Laura J Prevo; Carissa A Sanchez; Peter S Rabinovitch; Brian J Reid
Serum selenium levels in relation to markers of neoplastic progression among persons with Barrett's esophagus.
Journal of the National Cancer Institute 2003;95(10):750-7.
2003: Brian J Reid; Patricia L Blount; Peter S Rabinovitch
Biomarkers in Barrett's esophagus.
Gastrointestinal endoscopy clinics of North America 2003;13(2):369-97.
2002: Thomas L Vaughan; Alan R Kristal; Patricia L Blount; Douglas S Levine; Patricia C Galipeau; Laura J Prevo; Carissa A Sanchez; Peter S Rabinovitch; Brian J Reid
Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(8):745-52.
2002: Michael T Barrett; Ka Yee Yeung; Walter L Ruzzo; Li Hsu; Patricia L Blount; Robert Sullivan; Helmut Zarbl; Jeffrey Delrow; Peter S Rabinovitch; Brian J Reid
Transcriptional analyses of Barrett's metaplasia and normal upper GI mucosae.
Neoplasia (New York, N.Y.) 2002;4(2):121-8.
2001: DJ Wong; Thomas G Paulson; Laura J Prevo; Patricia C Galipeau; Gary Longton; Patricia L Blount; Brian J Reid
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium.
Cancer research 2001;61(22):8284-9.
2001: Peter S Rabinovitch; Gary Longton; Patricia L Blount; Douglas S Levine; Brian J Reid
Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.
The American journal of gastroenterology 2001;96(11):3071-83.
2001: Brian J Reid; Laura J Prevo; Patricia C Galipeau; Carissa A Sanchez; Gary Longton; Douglas S Levine; Patricia L Blount; Peter S Rabinovitch
Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression.
The American journal of gastroenterology 2001;96(10):2839-48.
2001: A K Dattamajumbar; Patricia L Blount; J A Myers; A H Proctor; B H Goldman; Brian J Reid; Roy W Martin
A low-cost fiber-optic instrument to colorimetrically detect patients with Barrett's esophagus for early detection of esophageal adenocarcinoma.
IEEE transactions on bio-medical engineering 2001;48(6):695-705.
2000: Brian J Reid; Patricia L Blount; Z Feng; Douglas S Levine
Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia.
The American journal of gastroenterology 2000;95(11):3089-96.
2000: Brian J Reid; Douglas S Levine; Gary Longton; Patricia L Blount; Peter S Rabinovitch
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets.
The American journal of gastroenterology 2000;95(7):1669-76.
2000: Douglas S Levine; Patricia L Blount; Rebecca E Rudolph; Brian J Reid
Safety of a systematic endoscopic biopsy protocol in patients with Barrett's esophagus.
The American journal of gastroenterology 2000;95(5):1152-7.